tiprankstipranks
GE Healthcare Technologies Inc (GEHC)
NASDAQ:GEHC
US Market

GE Healthcare Technologies Inc (GEHC) Stock Price & Analysis

928 Followers

GEHC Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$62.28 - $94.43
Previous Close$80.44
Volume2.43M
Average Volume (3M)2.78M
Market Cap
$36.72B
Enterprise Value$43.60B
Total Cash (Recent Filing)$2.56B
Total Debt (Recent Filing)$9.26B
Price to Earnings (P/E)23.5
Beta1.20
Jul 31, 2024
Dividend Yield0.15%
Share Statistics
EPS (TTM)3.43
Shares Outstanding456,465,369
10 Day Avg. Volume2,805,387
30 Day Avg. Volume2,780,648
Standard Deviation0.10
R-Squared0.32
Alpha-0.00609
Financial Highlights & Ratios
Price to Book (P/B)-5.40
Price to Sales (P/S)1.85
Price to Cash Flow (P/CF)21.60
P/FCF Ratio24.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.24
Enterprise Value/Gross Profit2.66
Enterprise Value/Ebitda15.50
Forecast
Price Target Upside14.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8

Bulls Say, Bears Say

Bulls Say
InnovationGE Healthcare has the potential to play a leadership role in the convergence of technology and healthcare, through the company’s AI-enabled medical devices.
Market DynamicsChina stimulus expected to be finalized represents a significant potential tailwind to performance in the second half of the year and beyond.
ValuationThe stock is now trading at a discount post-1Q, making the current valuation an attractive entry point.
Bears Say
Financial PerformanceSurprise Q1 revenue and EPS miss weighs heavily on shares.
Market ConditionsIf there is a delay or lingering uncertainty, China equipment buying may stay 'locked' and would put the 2024 guide at risk.
Product PerformanceImaging fell below expectations and Ultrasound was a touch light which both faced tough comps from last year.
---

Financials

Annual

Ownership Overview

7.67%33.57%24.41%34.35%
24.41% Other Institutional Investors
34.35% Public Companies and Individual Investors

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

GEHC FAQ

What was GE Healthcare Technologies Inc’s price range in the past 12 months?
GE Healthcare Technologies Inc lowest stock price was $62.28 and its highest was $94.43 in the past 12 months.
    What is GE Healthcare Technologies Inc’s market cap?
    Currently, no data Available
    When is GE Healthcare Technologies Inc’s upcoming earnings report date?
    GE Healthcare Technologies Inc’s upcoming earnings report date is Jul 31, 2024 which is in 9 days.
      How were GE Healthcare Technologies Inc’s earnings last quarter?
      GE Healthcare Technologies Inc released its earnings results on Apr 30, 2024. The company reported $0.9 earnings per share for the quarter, missing the consensus estimate of $0.907 by -$0.007.
        Is GE Healthcare Technologies Inc overvalued?
        According to Wall Street analysts GE Healthcare Technologies Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does GE Healthcare Technologies Inc pay dividends?
          GE Healthcare Technologies Inc pays a Thriceyearly dividend of $0.03 which represents an annual dividend yield of 0.15%. See more information on GE Healthcare Technologies Inc dividends here
            What is GE Healthcare Technologies Inc’s EPS estimate?
            GE Healthcare Technologies Inc’s EPS estimate is $0.98.
              How many shares outstanding does GE Healthcare Technologies Inc have?
              GE Healthcare Technologies Inc has 456,465,360 shares outstanding.
                What happened to GE Healthcare Technologies Inc’s price movement after its last earnings report?
                GE Healthcare Technologies Inc reported an EPS of $0.9 in its last earnings report, missing expectations of $0.907. Following the earnings report the stock price went down -14.284%.
                  Which hedge fund is a major shareholder of GE Healthcare Technologies Inc?
                  Among the largest hedge funds holding GE Healthcare Technologies Inc’s share is Dodge & Cox. It holds GE Healthcare Technologies Inc’s shares valued at 2B.
                    ---

                    Company Description

                    GE Healthcare Technologies Inc

                    GE HealthCare Technologies Inc is a global medical technology, pharmaceutical diagnostics, and digital solutions innovator company.
                    ---

                    GEHC Company Deck

                    ---

                    GEHC Earnings Call

                    Q1 2024
                    0:00 / 0:00
                    ---

                    GEHC Revenue Breakdown

                    54.12%54.12%17.68%16.07%11.79%0.34%
                    54.12% Imaging
                    17.68% Ultrasound
                    16.07% PCS
                    11.79% PDx
                    0.34% Other
                    tipranks
                    ---

                    GEHC Stock 12 Month Forecast

                    Average Price Target

                    $91.88
                    ▲(14.22% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"67":"$67","106":"$106","76.75":"$76.8","86.5":"$86.5","96.25":"$96.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":105,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$105.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":91.88,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$91.88</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":84,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$84.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[67,76.75,86.5,96.25,106],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2023","6":"Jan<br/>2024","9":"Apr<br/>2024","12":"Jul<br/>2024","25":"Jul<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,77.03,79.18153846153847,81.33307692307693,83.48461538461538,85.63615384615385,87.78769230769231,89.93923076923078,92.09076923076924,94.24230769230769,96.39384615384616,98.54538461538462,100.69692307692307,102.84846153846155,{"y":105,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,77.03,78.1723076923077,79.31461538461538,80.45692307692308,81.59923076923077,82.74153846153845,83.88384615384615,85.02615384615385,86.16846153846154,87.31076923076922,88.45307692307692,89.5953846153846,90.7376923076923,{"y":91.88,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,77.03,77.56615384615385,78.10230769230769,78.63846153846154,79.17461538461538,79.71076923076923,80.24692307692308,80.78307692307692,81.31923076923077,81.85538461538462,82.39153846153846,82.92769230769231,83.46384615384615,{"y":84,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":82.5,"date":1689897600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.78,"date":1691107200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.14,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.35,"date":1696550400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.49,"date":1698969600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.33,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.53,"date":1704412800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":73.86,"date":1706832000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":92.65,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.41,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.44,"date":1714694400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.31,"date":1717718400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.03,"date":1720137600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Baxter International
                    Becton Dickinson
                    Boston Scientific
                    Danaher

                    Best Analysts Covering GEHC

                    1 Year
                    Larry BiegelsenWells Fargo
                    1 Year Success Rate
                    7/9 ratings generated profit
                    78%
                    1 Year Average Return
                    +10.18%
                    assigned a buy rating 3 months ago
                    Copying Larry Biegelsen's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +10.18% per trade.
                    Popular Stocks
                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis